Drug Manufacturers Specialty Generic Industry Analysis

84 companies analyzed • Returns from -361.7% to +380.6% • Data through May 1, 2026

Company List (84 Results)

View:

Sort:

Industry Performance

(84/84 companies)

2025-05-05 → 2026-05-01

Weighted Avg

+6.5%

Median

+4.3%

Best

+380.6%

Worst

-361.7%

Returns Distribution

Top 5

1. AKAN+380.6%2. IXHL+354.8%3. ASRT+341.4%4. TLRY+265.3%5. FLGC+237.4%

Bottom 5

1. BGM-361.7%2. ZYBT-263.4%3. ALVOW-182.6%4. IMCC-169.6%5. INM-143.5%

1–20 of 84

Page 1 of 5

Methodology

The Weighted Average return (+6.5%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

81 companies with market cap data included: AKAN, IXHL, ASRT, TLRY, FLGC, IRWD, YCBD, BIOA, SHPH, EVOK and 71 more...

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Drug Manufacturers Specialty Generic Industry Analysis

Company List (84 Results)

Industry Performance

AKAN

IXHL

ASRT

TLRY

FLGC

IRWD

YCBD

BIOA

SHPH

EVOK

INDV

ESPR

PAHC

AVDL

ELAN

TEVA

AYTU

KNSA

UTHR

VTRS